Description

Symposium on Cancer Vaccines 

Ghent University, Faculty of Pharmaceutics, Octobre 20^th 2025

Organizers: dr. Ine Lentacker, dr. Rein Verbeke, Prof. Dmitri Krysko, Prof. Stefaan De Smedt

Cancer vaccines : where do we come from?

Collen-Francqui Chair 2025 – Prof . Pierre Coulie

Antigen Discovery 

9u15 -10u30

T-cell epitope prediction and immunomonitoring using artificial intelligence

Pieter Meysman- UA

Immunopeptidomics for cancer antigen discovery

Francis Impens - VIB-UGent

Single-Cell Analysis During Checkpoint Immunotherapy to Reveal the Tumor Antigen Landscape Driving Treatment response and Advance Cancer Vaccine Development

Diether Lambrechts - KULeuven

Coffee Break

Antigen Presentation 

11u -11u50)

An mRNA as a toolbox for patient-tailored vaccine development

Karine Breckpot -VUB

Dendritic cells armed with ferroptotic tumor lysates

 Dmitri Krysko -UGent

Role of myeloid cells in antitumor immunity

11u50 -13u30

The different flavours of the tumor-associated macrophage

Jo Van Ginderachter -VIB-VUB

Lunch

Navigating the Complexities of Cancer Cell Diversity and Adaptability

Chris Marine -KULeuven

mRNA cancer vaccines 

13u30 -14u45

Decoding the adjuvants activity of mRNA-based lipid nanoparticle vaccins, how do DCs recognise them?

Sophie Janssen  - VIB-UGent

Galsomes-NEO cancer vaccine platform

(GRGN - UGent)

Ongoing mRNA vaccination projects at UA

Eva Lion - UA

Coffee Break

Clinical trials with cancer vaccines

15u30 -16u45

Mutant IDH-directed immunotherapies in Glioma

Lukas Bunse  (German Cancer Research Center)

mRNA-modified dendritic cell therapy program at UZ Gent: from bench to bedside and back.

Karim Vermaelen (UZGent)

Forward outlook to cancer vaccination

Collen-Francqui Chair 2025 – Prof . Pierre Coulie

Reception